Denis Jullien Selected Research

Denis Jullien Research Topics

Disease

9	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2022 - 08/2012
7	Neoplasms (Cancer) 12/2021 - 03/2009
4	Inflammation (Inflammations) 01/2022 - 01/2020
3	Melanoma (Melanoma, Malignant) 11/2021 - 10/2010
2	Dermatomyositis (Dermatopolymyositis) 12/2021 - 01/2019
2	Pemphigus (Pemphigus Vulgaris) 01/2020 - 05/2017
2	Skin Neoplasms (Skin Cancer) 04/2017 - 08/2014
2	Hidradenitis Suppurativa 06/2016 - 11/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Myocardial Infarction 01/2022
1	Immune System Diseases (Immune Disorders) 12/2021
1	Obesity 01/2021
1	Onycholysis 01/2021
1	COVID-19 01/2021
1	Blister (Bulla) 01/2021
1	Infections 01/2021
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2020
1	Histiocytosis 01/2020
1	Edema (Dropsy) 01/2020
1	Chilblains (Chilblain) 01/2020
1	Acanthoma 04/2019
1	Pityriasis Rubra Pilaris 01/2019
1	Psoriatic Arthritis 10/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2017
1	Pathologic Complete Response 05/2017
1	Muscular Diseases (Myopathy) 05/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2017
1	Vasculitis (Vasculitides) 02/2015
1	Acrodermatitis (Gianotti Crosti Syndrome) 01/2015
1	Hypersensitivity (Allergy) 01/2015
1	Necrosis 01/2015
1	Alopecia Areata 06/2014
1	Genomic Instability 03/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2012
1	Breast Neoplasms (Breast Cancer) 10/2010
1	Neoplasm Metastasis (Metastasis) 10/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2002

Drug/Important Bio-Agent (IBA)

6	Biological ProductsIBA 03/2022 - 01/2015
4	AntibodiesIBA 01/2019 - 01/2015
2	Pharmaceutical PreparationsIBA 03/2022 - 01/2015
2	AutoantibodiesIBA 12/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	Rituximab (Mabthera)FDA Link 01/2020 - 05/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 05/2017
2	Acitretin FDA Link 01/2019 - 01/2015
2	Tacrolimus (Prograf)FDA LinkGeneric 11/2014 - 08/2014
2	Phosphotransferases (Kinase)IBA 03/2012 - 01/2002
2	cdc25 PhosphatasesIBA 04/2009 - 03/2009
1	apremilastIBA 03/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	IA 4IBA 11/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	DesmogleinsIBA 01/2020
1	FibrinIBA 01/2020
1	Infliximab (Remicade)FDA Link 01/2020
1	EnzymesIBA 01/2020
1	Cladribine FDA LinkGeneric 01/2020
1	ImmunosorbentsIBA 01/2020
1	ixekizumabIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019
1	beta CateninIBA 08/2018
1	Calbindin 2IBA 08/2018
1	Immunologic Factors (Immunomodulators)IBA 10/2017
1	Prednisone (Sone)FDA LinkGeneric 05/2017
1	Azathioprine (Imuran)FDA LinkGeneric 04/2017
1	Ustekinumab (CNTO 1275)FDA Link 01/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2014
1	VaccinesIBA 08/2012
1	3- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamideIBA 03/2012
1	Chemokine CCL21IBA 10/2010
1	LigandsIBA 10/2010
1	ChemokinesIBA 10/2010
1	Antineoplastic Agents (Antineoplastics)IBA 04/2009
1	quinone (benzoquinone)IBA 03/2009
1	2- (2,5- difluorophenyl)- 6- ((3- (methyl(3- ((2- methyl- 4,7- dioxo- 4,7- dihydro- 1,3- benzothiazol- 5- yl)amino)propyl)amino)propyl)amino)- 1,3- benzoxazole- 4,7- dioneIBA 03/2009

Therapy/Procedure

9	Therapeutics 01/2021 - 03/2009
3	Liver Transplantation 04/2019 - 08/2014
2	Transplantation 11/2021 - 04/2017
2	Organ Transplantation 11/2021 - 11/2017
2	Biological Therapy 01/2021 - 01/2015
2	Kidney Transplantation 04/2017 - 11/2014
1	Colectomy 01/2022
1	Emergency Treatment 01/2022
1	Aftercare (After-Treatment) 01/2020